Search

Search Constraints

You searched for: Author/Creator Northfelt, Donald W.

Search Results

1. A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma. Issue 9 (2nd September 2018)

2. A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non–Small-Cell Lung Cancer. Issue 1 (January 2015)

3. A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non–Small-Cell Lung Cancer: North Central Cancer Treatment Group (NCCTG)-N0321. Issue 1 (January 2015)

5. Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome‐Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2. Issue 1 (18th March 2019)

9. Change in 21‐gene Recurrence Score result after exposure to neo‐adjuvant endocrine therapy in patients with operable breast cancer. Issue 7 (26th December 2019)

10. Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma. Issue 5 (10th March 2017)